Severe loss of quality of life, due to symptoms such as debilitating fatigue, insomnia (B12 is required for synthesis of melatonin), mental illness, and neurological symptoms
Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months
Vitamin B(1)(2) status, cognitive decline and dementia: a systematic review of prospective cohort studies
In the afternoon, we will take the train to return to the Ollantaytambo station, where a transfer awaits you to direct you to the bus that will take you back to the city of Cusco
Understanding these age-specific needs helps doctors give better support to their patients
You might ask, why cant people use other forms of B12